Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
I-020201 for chronic diabetic foot ulcers
NCT00915486Phase 2Completed
- Sponsor
- Kuros Biosciences
- Start
- May 2009
- Primary completion
- Mar 2012
- Countries
- 6
01
Overview
Phase 2, randomised, double-blind trial of I-020201 in diabetic foot ulcer (DFU) (5 arms), sponsored by Kuros Biosciences. Primary endpoint: Percentage reduction in ulcer surface area at 4 weeks. Started May 2009; status: completed.
02
Drugs
I-020201
03
Conditions
diabetic foot ulcer (DFU)
Beyond the preview
Go deeper on NCT00915486.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00915486.